RESEARCH PAPER
Oral candidiasis profile of the Indonesian HIV-infected pediatric patients at UPIPI Dr. Soetomo General Hospital, Surabaya, Indonesia
 
More details
Hide details
 
Submission date: 2018-01-31
 
 
Final revision date: 2018-04-08
 
 
Acceptance date: 2018-04-30
 
 
Publication date: 2018-11-30
 
 
HIV & AIDS Review 2018;17(4):272-277
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Indonesia is stated as one of Asia’s fastest growing HIV epidemics, yet to date, studies on the characteristics of human immunodeficiency virus (HIV) infection, especially on Indonesian children, are very limited. Opportunistic infections, such as oral candidiasis have been an integral part of the disease and related to important diagnostic and prognostic values of the infection. The aim of this study was to determine the candidiasis profile of the Indonesian HIV-infected pediatric patients, and to correlate the clinical types of candidiasis with highly active antiretroviral therapy (HAART) use and the level of immune suppression.

Material and methods:
HIV-infected pediatric patients attending the Intermediate Care and Infectious Disease Centre (UPIPI), Dr. Soetomo Hospital outpatient clinic between June-October 2017 were examined intraorally for the presence of oral candidiasis. Identification of Candida species was based on colony morphology on CHROM-Agar, hydrolysis of urea, carbohydrate fermentation tests, thermotolerance test, and microscopic morphology on slide culture from oral swab samples. Other relevant data regarding each patient were also obtained from medical records.

Results:
Oral candidiasis was found in 55.17% patients, with 3 different clinical types: pseudomembranous (21.43%), erythematous (14.29%), and angular cheilitis (46.3%). There was a significant relationship between HAART with erythematous type (p < 0.05) and even stronger with the pseudomembranous type of Candida (p < 0.01). There was significant relationship between the level of immune suppression and pseudomembranous type (p < 0.05) and even stronger with the erythematous type (p < 0.01).

Conclusions:
Concurrent pseudomembranous and erythematous candidiasis may indicate advanced progression of HIV-infected pediatric patients, therefore further studies are required to validate our findings.

 
REFERENCES (30)
1.
The Joint United Nations Program on HIV/AIDS. UNAIDS data book 2017. Available at: http://www.unaids.org/sites/de... (Accessed: 10.01.2018).
 
2.
Wisaksana R, Alisjahbana B, van Crevel R, et al. Challenges in delivering HIV-care in Indonesia: experience from a referral hospital. Acta Med Indonesia 2009; 41 Suppl 1: 45-51.
 
3.
The Joint United Nations Program on HIV/AIDS. UNAIDS 2011-2015 strategy: Getting to Zero. Available at: http://www.unaids.org/sites/de... (Accessed: 14.01.2018).
 
4.
The Joint United Nations Program on HIV/AIDS. ASEAN leaders commit to “Getting to Zero”. Available at: http://www.unaids.org/en/resou... sean (Accessed: 20.01.2018).
 
5.
Pisani E, Olivier KM, Nugroho K. Indonesia’s road to universal health coverage: a political journey. Health Policy Plan 2017; 32: 267-276.
 
6.
National AIDS Commission Indonesia. National consultation on legal and policy barriers to HIV in Indonesia. Available at: https://hivlawcommission.org/w...- hhd-2015-national-consultation-legal-policy-barriers-hiv-indonesia.pdf (Accessed: 21.01.2018).
 
7.
Directorate General CDC & EH – Ministry of Health of Indonesia. Laporan situasi perkembangan HIV-AIDS di Indonesia Jan-Maret 2017. Available at: http://www.aidsindonesia.or.id... (Accessed: 10.01.2018).
 
8.
Sharma G, Oberoi SS, Vohra P, Nagpal A. Oral manifestations of HIV/AIDS in Asia: Systematic review and future research guidelines. J Clin Exp Dent 2015; 7: e419-e427.
 
9.
Nazemisalman B, Vahabi S, Bayat N, Ansari A. Early diagnosis of oral manifestation in HIV infected pediatric patients, a review of current literature. Pediatr Neonatal Biol 2016; 3: 001.
 
10.
Gaitán-Cepeda LA, Sánchez-Vargas O, Castillo N. Prevalence of oral candidiasis in HIV/AIDS children in highly active antiretroviral therapy era: A literature analysis. Int J STD AIDS 2015; 26: 625-632.
 
11.
Indonesian Law and Regulations. Undang-undang Republik Indonesia nomor 23 tahun 2002 tentang perlindungan anak. Available at: http://www.kinerja.or.id/pdf/8... (Accessed: 10.04.2017).
 
12.
EC-Clearinghouse. Classification and diagnostic criteria for oral lesions in HIV infection. EC-Clearinghouse on Oral Problems Related to HIV Infection and WHO Collaborating Centre on Oral Manifestations of the Immunodeficiency Virus. J Oral Pathol Med 1993; 22: 289-291.
 
13.
World Health Organization. WHO case definitions of HV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. WHO Press, France 2007; pp. 14-15.
 
14.
Ministry of Health Republic of Indonesia. Pedoman penerapan terapi HIV anak 2014. Available at: http://www.spiritia.or.id/doku... (Accessed: 10.04.2017).
 
15.
Leao JC, Riberiro CMB, Carvalho AAT, et al. Oral complications of HIV disease. Clinics 2009; 64: 459-470.
 
16.
Byadarahally Raju S, Rajappa S. Isolation and identification of Candida from the oral cavity. ISRN Dent 2011; 2011: 487921.
 
17.
Pongsiriwet S, Iamaroon A, Sriburee P, et al. Oral colonization of Candida species in perinatally HIV-infected children in northern Thailand. J Oral Sci 2004; 46: 101-105.
 
18.
Rao KV, Chitturi RT, Kattappagari KK, et al. Impact of highly active antiretroviral therapy on oral manifestations of patients with human immunodeficiency virus/acquired immuno deficiency syndrome in South India. Indian J Sex Transm Dis 2015; 36: 35-39.
 
19.
Ponnam SR, Srivastava G, Theruru K. Oral manifestations of human immunodeficiency virus in children: An institutional study at highly active antiretroviral therapy centre in India. J Oral Maxillofac Pathol 2012; 16: 195-202.
 
20.
Taiwo OO, Hassan Z. The impact of Highly Active Antiretroviral Therapy (HAART) on the clinical features of HIV-related oral lesions in Nigeria. AIDS Res Ther 2010; 7: 19.
 
21.
Wilson EMP, Sereti I. Immune restoration after antiretroviral therapy: the pitfalls of hasty or incomplete repairs. Immunol Rev 2013; 254: 343-354.
 
22.
Flanagan MA, Barasch A, Koenigsberg SR, et al. Prevalence of oral soft tissue lesions in HIV-infected minority children treated with highly active antiretroviral therapies. Pediatr Dent 2000; 22: 287-291.
 
23.
Khongkunthian P, Grote M, Isaratanan W, et al. Oral manifestations in 45 HIV-positive children from Northern Thailand. J Oral Pathol Med 2001; 30: 549-552.
 
24.
Hamza OJ, Matee MI, Simon EN, et al. Oral manifestations of HIV infection in children and adults receiving highly active anti-retroviral therapy [HAART] in Dar es Salaam, Tanzania. BMC Oral Health 2006; 6: 12.
 
25.
Patil S, Rao RS, Majumdar B, Anil S. Clinical Appearance of Oral Candida Infection and Therapeutic Strategies. Front Microbiol 2015; 6: 1391.
 
26.
Montessori V, Press N, Harris M, et al. Adverse effects of antiretroviral therapy for HIV infection. CMAJ 2004; 170: 229-238.
 
27.
Gruber A, Lell CP, Speth C, et al. Human immunodeficiency virus type 1 TAT binds to Candida albicans, inducing hyphae but augmenting phagocytosis in vitro. J Immunol 2001; 104: 455-461.
 
28.
Huber MA, Redding SW, Sankar V, Woo SB. Infectious Disease in Greenberg & Glick: Burket’s Oral Medicine. 12th ed. BC Decker Inc., Hamilton 2015; pp. 560-561.
 
29.
Mahajan B, Bagul N, Desai R, et al. Pseudomembranous Type of Oral Candidiasis is Associated with Decreased Salivary Flow Rate and Secretory Immunoglobulin A Levels. Mycopathologia 2015; 180: 75-80.
 
30.
Vylkova S, Nayyar N, Li W, Edgerton M. Human β-Defensins Kill Candida albicans in an Energy-Dependent and Salt-Sensitive Manner without Causing Membrane Disruption. Antimicrob Agents Chemother 2007; 51: 154-161.
 
eISSN:1732-2707
ISSN:1730-1270
Journals System - logo
Scroll to top